# Pharmacy Blinding Access Control Hardening Report

## 1. Overview
The Pharmacy Runtime Ledger has been significantly hardened to natively support double-blind, single-blind, and open-label clinical trials. The previous Role-Based Access Control (RBAC) was deemed insufficient for GCP compliance, as role alone (e.g., "Pharmacist" or "Coordinator") does not dictate whether that individual is explicitly `BLINDED` or `UNBLINDED` to the treatment arm assignments. 

This enhancement shifts the architecture from simple Role-Based access to **Attribute-Based Access Control (ABAC)**, incorporating the `BlindScope`.

## 2. Structural Implementations

### 2.1 The `BlindScope` Paradigm
Added `BlindScope` to the `ActorDelegationContext` (resolved from the future DOA module).
- `BLINDED`: Standard clinical team (PI, CRC).
- `UNBLINDED`: Independent dispensing team (Unblinded Pharmacist/Unblinded CRA).
- `SPONSOR_UNBLINDED`: Global sponsor QA.
- `SYSTEM_REDACTED`: A string literal used to overwrite sensitive data in the view layer.

### 2.2 Unblinded Fields in PharmacyEvent
The `PharmacyEvent` schema was expanded to hold highly sensitive unblinded data:
- `treatment_assignment` (e.g., "Active" or "Placebo")
- `unblinded_preparation_instructions` (e.g., "Draw 10mL if Active, 5mL if Placebo")
- `unblinded_sponsor_note` (Sensitive communications regarding lot release)
- `active_placebo_indicator` (Nested in `source_evidence`)

### 2.3 Redaction Engine (`resolvePharmacyViewForActor`)
The system now implements a strict redaction layer. If an actor's `BlindScope` is `BLINDED`, the redaction engine intercepts the `PharmacyEvent` and `InventoryState` prior to returning them to the UI. 

Sensitive fields are mathematically overwritten with the literal string `"SYSTEM_REDACTED"`.
*Example:* A blinded coordinator viewing a `SPONSOR_RELEASE` event will see the `kit_id` and the `event_time`, but the `unblinded_sponsor_note` explaining why the kit was released will be replaced with `"SYSTEM_REDACTED"`.

### 2.4 Unblinded Hard Guards
The `validateDelegationPolicyForAction` function was updated to block blinded actors from approving tasks that inherently reveal unblinded information.
Blinded actors **CANNOT**:
- `VIEW_UNBLINDED_INVENTORY` (Total counts can reveal allocation ratios).
- `VIEW_TREATMENT_ASSIGNMENT`
- `RECONCILE_ACCOUNTABILITY` (Reconciling total vials against total patients reveals study-wide dispensing patterns).
- `APPROVE_DESTRUCTION` (The destruction log explicitly groups Active vs Placebo vials).

## 3. Test Coverage Strategy
A test suite (`tests/pharmacy-blinding-access-policy.test.ts`) was authored to guarantee that:
- Blinded users see redacted payloads.
- Blinded users cannot execute unblinded-only operations.
- Unblinded users retain full fidelity.
- Source exports explicitly scrub sensitive dictionaries.

## 4. Final Assessment
**Pharmacy Blinding Access Control: `READY`**

**Justification:** The ledger architecture is now functionally complete for multi-arm double-blind randomized trials. The separation of `Role` and `BlindScope` ensures that Vilo OS can handle the complex operational permutations of modern clinical pharmacy environments while physically preventing accidental unblinding events (which are critical FDA protocol deviations).
